PharmaVOICE Editors' Blog
Showing posts with label cardiology. Show all posts
Showing posts with label cardiology. Show all posts
Tuesday, May 21, 2013
Top Industry Research on Afib Prevention to be Revealed
Posted by
Anonymous
at
5:55 PM
Labels:
afib,
atrial fibrillation,
avertAF,
Camm,
cardiology
Wednesday, May 4, 2011
Free Webinar: What are Galectins and how can they advance heart failure treatment?
Posted by
Dan Limbach
at
1:21 PM
Dan Limbach
Galectin-3: Enabling a New Pharmaceutical Paradigm in Treatment of Heart Failure
Register Now
This session will provide a unique look at the role of the protein galectin-3 in pharmacological treatment of heart failure. Galectin-3 may transform heart failure from a signs and symptoms based definition of disease to one based on distinct disease processes. Galectin-3 segmentation may be relevant for efficacy of certain drug classes and galectin-3 inhibition may one day offer a new approach to disease modifying therapy in heart failure.
Sponsored by BG Medicine and brought to you by PharmaVOICE.
Labels:
BG Medicine,
cardiology,
galectin,
heart failure,
pharmavoice,
webinar,
weblinx
Subscribe to:
Posts (Atom)
